Ultralife Corp. Reports Strong Growth in Q2 2024 Financial Results
Ultralife Corporation, a prominent player in advanced power solutions and communication systems, has released its financial results for the second quarter of 2024. The report indicates a significant turnaround from the previous year, showcasing the company's resilience in the face of challenges, including a ransomware attack that impacted operations in early 2023.
1. Financial Highlights
Income Statement Overview
For the six-month period ending June 30, 2024, Ultralife reported a net income attributable to common shareholders of $5.86 million, an increase of $2.86 million from $2.99 million in the same period of 2023. The company's basic and diluted earnings per share (EPS) rose to $0.36 and $0.35, respectively, compared to $0.19 for both metrics in 2023. Adjusted EPS, which excludes deferred tax provisions, was reported at $0.44 on a diluted basis for the 2024 period, up from $0.24 in 2023.
| Jul 2023 | Jul 2024 | |
|---|---|---|
Net Income | 2.53M | 10.06M |
Net Income to Non-controlling Interest | 15K | -13K |
Profit | 2.54M | 10.05M |
Net Income Continuing | 2.54M | 10.05M |
Income Tax Expense | 997K | 2.26M |
Pretax Income | 3.54M | 12.31M |
Non-operating Income | 221K | -1.44M |
Operating Income | 3.32M | 13.76M |
Revenue | 143.9M | 168.9M |
Costs and Expenses | 140.6M | 155.1M |
Cost of Revenue | 111.1M | 124.7M |
Operating Expenses | 29.49M | 30.44M |
Research & Development | 7.36M | 7.47M |
Selling, General & Administrative | 22.13M | 22.97M |
Revenue and Expenses
Ultralife generated revenues of $42.98 million in Q2 2024, marking a slight increase from $42.69 million in Q2 2023. The company's operating income for the period stood at $3.91 million, while total costs and expenses were reported at $39.06 million, up from $39.02 million in the previous year. This reflects a focused effort on managing expenses while driving revenue growth.
2. Operating Segments
Ultralife operates through two primary segments: Battery & Energy Products and Communications Systems. The Battery segment includes a diverse array of products such as lithium batteries and uninterruptable power supplies, while the Communications segment encompasses RF amplifiers and integrated communication systems. This diverse product offering positions Ultralife strategically within both consumer and governmental markets.
3. Balance Sheet Analysis
As of June 30, 2024, Ultralife's total assets amounted to $165.3 million, down from $173.0 million in 2023. Current assets were reported at $83.78 million, comprising $6.69 million in cash and equivalents, $31.05 million in current receivables, and $41.39 million in inventories. Total liabilities decreased to $36.47 million from $55.71 million a year ago, which reflects improved management of debt and operational costs.
| Jul 2023 | Jul 2024 | |
|---|---|---|
Total Assets | 173.0M | 165.3M |
Total Current Assets | 87.82M | 83.78M |
Cash and Equivalents | 8.28M | 6.69M |
Net Inventories | 46.06M | 41.39M |
Accounts Receivable | 28.63M | 31.05M |
Prepaid Expenses | 4.85M | 4.65M |
Total Non-current Assets | 85.25M | 81.52M |
Intangible Assets | 53.05M | 52.15M |
Non-current Deferred Tax Assets | 11.08M | 9.08M |
Net PP&E | 21.12M | 20.28M |
Total Liabilities and Equity | 175.3M | 169.8M |
Total Liabilities | 55.71M | 36.47M |
Total Current Liabilities | 29.20M | 20.57M |
Accounts Payable and Accrued Liabilities | 20.86M | 12.00M |
Current Debt | 2M | 2M |
Other Current Liabilities | 6.34M | 6.57M |
Total Non-current Liabilities | 26.51M | 15.89M |
Long-term Debt | 22.64M | 9.97M |
Non-current Deferred Tax Liabilities | 1.87M | 1.64M |
Other Non-current Liabilities | 1.99M | 4.27M |
Total Equity and Non-controlling Interests | 119.6M | 133.3M |
Total Equity | 119.5M | 133.2M |
Non-controlling Interests | 145K | 132K |
4. Cash Flow Insights
Ultralife faced a net cash outflow of $3.40 million in Q2 2024, primarily driven by financing activities that included debt repayments of $13.17 million. Despite this, the company reported a positive cash flow from operating activities of $8.92 million, indicating strong operational performance amidst ongoing market challenges.
| Jul 2023 | Jul 2024 | |
|---|---|---|
Net Change in Cash | 3.16M | -1.59M |
Effect of Exchange Rate Changes | -333K | -94K |
Net Cash from Operating Activities | 2.52M | 10.38M |
Operating Profit | 2.54M | 10.05M |
Adjustment to Operating Profit | -23K | 337K |
Net Cash from Investing Activities | -2.10M | -2.27M |
Productive Assets | 2.10M | 2.27M |
Net Cash from Financing Activities | 3.08M | -9.61M |
Debt | 3.1M | -12.72M |
Equity Issuance/Repurchase | 65K | 3.12M |
Other Financing Activities | -79K | -8K |
5. Cybersecurity Challenges
The management noted the ongoing impact of a ransomware cyberattack that occurred in January 2023. This incident affected the company's ability to process orders and manage service delivery effectively. Ultralife is currently pursuing cybersecurity insurance claims to cover the costs incurred from engaging external cybersecurity experts and the resulting business interruption.
6. Conclusion
Ultralife Corporation’s Q2 2024 results reflect a robust recovery trajectory, underpinned by strategic operational management and a diversified product portfolio. The company's focus on enhancing its core competencies in battery technology and communication systems is expected to drive further growth and stability in the coming quarters. As Ultralife navigates the aftermath of its cybersecurity challenges, continued vigilance and investment in technology will be crucial for sustaining its market position and achieving long-term financial goals.
